Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Foamix Pharmaceuticals Ltd. (FOMX)

2.85   -0.08 (-2.73%) 10-23 16:00
Open: 2.97 Pre. Close: 2.93
High: 2.97 Low: 2.77
Volume: 1,627,231 Market Cap: 174M
Foamix Pharmaceuticals Ltd is a clinical-stage specialty pharmaceutical company. It is engaged in developing and commercializing minocycline foam for the treatment of acne, rosacea, impetigo and other skin conditions. Its products include FMX101 & FMX103.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.974 - 2.992 2.992 - 3.005
Low: 2.728 - 2.75 2.75 - 2.766
Close: 2.82 - 2.853 2.853 - 2.877

Technical analysis

as of: 2019-10-23 4:51:31 PM
Stoxline posted a STRONG SELL today, same as yesterday. Downward movement continues.
Target: Six months: 3.84     One year: 4.38
Support: Support1: 2.53    Support2: 2.10
Resistance: Resistance1: 3.28    Resistance2: 3.75
Pivot: 2.90
Moving Average: MA(5): 3.09     MA(20): 2.93
MA(100): 2.78     MA(250): 3.31
MACD: MACD(12,26): -0.03     Signal(9): -0.04
Stochastic oscillator: %K(14,3): 52.17     %D(3): 63.36
RSI: RSI(14): 44.34
52-week: High: 5.08  Low: 1.97  Change(%): -40.0
Average Vol(K): 3-Month: 111737  10-Days: 221788

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
FOMX has closed above bottom band by 44.2%. Bollinger Bands are 21.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Warning: file_get_contents( failed to open stream: HTTP request failed! HTTP/1.1 402 Payment Required in /home/content/81/11032181/html/www/stoxline/quote.php on line 283

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 61.00
Shares Float (M) 35.90
% Held by Insiders 0.70
% Held by Institutions 291.23
Shares Short (K) 3890
Shares Short P. Month (K)

Stock Financials

EPS -1.239
Book Value (p.s.) 1.110
PEG Ratio 0.02
Profit Margin
Operating Margin -3228.14
Return on Assets (ttm) -60.2
Return on Equity (ttm) -122.3
Qtrly Rev. Growth
Gross Profit (p.s.) 0.059
Sales Per Share
EBITDA (p.s.) -1.071
Qtrly Earnings Growth
Operating Cash Flow (M) -61.50
Levered Free Cash Flow (M) -39.04

Stock Valuations

P/E -2.30
P/E Growth Ratio -0.03
P/BV 2.57
P/S 4346249728.00
P/CF -2.83

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.